More tools:Markets·Screener·Research·Chat

DexCom, Inc. (DXCM) Financial Statements

DexCom, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SKZG99
XNAS · usd
84.82▼ 3.09 (-3.51%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close87.90
Day's Range87.65 – 89.00
52-Week Range54.11 – 92.59
Volume2.3M
Avg Volume4.7M
Share Statistics
Shares Outstanding
Employees11.1K
ExchangeXNAS
Listed2005-04-14
Share count as of July 23, 2026
Loading Income Statement…
Key questions about DexCom, Inc. (DXCM)
What is DexCom, Inc.'s Market Cap?
DexCom, Inc.'s Market Cap is $32.0B, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s Enterprise Value?
DexCom, Inc.'s Enterprise Value is $31.0B, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s Trailing P/E?
DexCom, Inc.'s Trailing P/E is 32.0×, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s Price / Sales?
DexCom, Inc.'s Price / Sales is 6.4×, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s EV / Revenue?
DexCom, Inc.'s EV / Revenue is 6.2×, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s EV / EBITDA?
DexCom, Inc.'s EV / EBITDA is 22.9×, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s Revenue (TTM)?
DexCom, Inc.'s Revenue (TTM) is $5.0B, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s Net Income (TTM)?
DexCom, Inc.'s Net Income (TTM) is $999.7M, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s EBITDA?
DexCom, Inc.'s EBITDA is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is DexCom, Inc.'s Diluted EPS (TTM)?
DexCom, Inc.'s Diluted EPS (TTM) is 2.65, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+13.1%+15.0%+13.1%+21.6%
Cost of sales
Gross profit
% of revenue63.4%62.9%62.9%60.5%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue39.1%41.5%37.3%40.4%
Operating income
% of revenue24.3%21.4%25.6%20.1%
Other income (expense), net
Income before income taxes
Income tax expense
Net income
% of revenue19.0%16.7%21.2%23.5%
Basic net income per share (in USD per share)
Diluted net income per share (in USD per share)